Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma
口服生物可利用的 CDK9/2 抑制剂在 MYCN 驱动的神经母细胞瘤中显示出基于机制的治疗潜力
期刊:Journal of Clinical Investigation
影响因子:13.3
doi:10.1172/JCI134132
Evon Poon, Tong Liang, Yann Jamin, Susanne Walz, Colin Kwok, Anne Hakkert, Karen Barker, Zuzanna Urban, Khin Thway, Rhamy Zeid, Albert Hallsworth, Gary Box, Marli E Ebus, Marco P Licciardello, Yordan Sbirkov, Glori Lazaro, Elizabeth Calton, Barbara M Costa, Melanie Valenti, Alexis De Haven Brandon,